Although the association with a higher risk of cutaneous melanoma is established, and it seems reasonable to hypothesize that POT1 variants may confer a wider cancer risk, given the biological processes in which it is involved, a convincing demonstration of the clinical association between the variants and the observed cancers to be possibly included in the spectrum of POT1–TPD is often missing. Here, POT1 is linked to cutaneous melanoma.